Preventing disturbing migraine aura with lamotrigine: an open study. - Test2 - elhamkhani - TriplyDB

Preventing disturbing migraine aura with lamotrigine: an open study.

Preventing disturbing migraine aura with lamotrigine: an open study.

http://www.wikidata.org/entity/Q34650041

about

An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology.Italian guidelines for primary headaches: 2012 revised version Migraine, celiac disease, and cerebral calcifications: a new case.Visual Snow: a Potential Cortical Hyperexcitability Syndrome.Late-life migraine accompaniments: A narrative review.Evidence-based medicine in migraine prevention.New drugs for migraine Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders.Optimizing prophylactic treatment of migraine: Subtypes and patient matching.Migraine with aura: conventional and non-conventional treatments.The typical duration of migraine aura: a systematic review.Sodium channel antagonists for the treatment of migraine.The visual system in migraine: from the bench side to the office.Persistent and Repetitive Visual Disturbances in Migraine: A Review.Menstrual Migraine and Treatment Options: Review.Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events?Killing two birds with one stone: successful opioid monotherapy in intractable migraine-triggered epilepsy, a case series.Management of vestibular migraine.Basilar-type migraine patients responsive to lamotrigine: a 5-year follow-up.Familial and sporadic hemiplegic migraine: diagnosis and treatment.Bending the rule of monotherapy for migraine prevention?Migraine with prolonged aura: phenotype and treatment.Are cortical spreading depression and headache in migraine causally linked?Possible Involvement of the CACNA1E Gene in Migraine: A Search for Single Nucleotide Polymorphism in Different Clinical Phenotypes.Familial hemiplegic migraine treated by sodium valproate and lamotrigine.Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).

P2860

Q25257354-2046813E-EC51-4B08-9639-8D81F1384A7F Q30466790-6861BB78-3021-4BB1-A397-0C80B74625B1 Q34453107-B0505029-48DE-493D-B9CD-59D5B204D7AB Q34554230-A2374F07-EF50-4BF1-B13F-E8A1E6EF21F6 Q35518633-D9D627D4-6CC1-4931-ABBA-88B2A76D32F6 Q36153368-21F680B5-FDDF-445E-936E-B6FA8C02B0F8 Q36332611-99795D35-9257-49F9-9114-6B85D6F64B8B Q36673011-1CEFBC69-85D6-497D-9076-CD487606A124 Q37052803-09DDDB47-66C8-45E0-8550-F0A72286B5CD Q37870798-861503B9-BDE0-437B-B8D6-D7A23F9C254F Q38087899-A9BAFE47-2C11-4892-B2C2-3B00BFF91656 Q38221187-9CC38DE8-504A-44A6-9891-00FCEB472F74 Q38347056-02F3B196-9D12-47BA-8376-66BAC0E485F2 Q38974798-062AA3CE-BA75-4F11-B228-CFC4A156812E Q39026779-04D3717F-B7D5-4DBE-8A1E-618407950CDD Q39107282-81EAEB93-AC9B-4442-ADC6-51B723332276 Q39137721-C7088A3A-2104-48B7-A2B9-2E65A2B01425 Q41765630-E231BE88-F6E2-4DEE-BCC8-0BE1049EBF48 Q44295519-7B7564B6-EE3D-4CE7-8220-7B1933CF54FE Q46069840-B57F915F-4F1C-4E35-8B7C-385218551A92 Q46543679-F72DA9C2-75DB-4D60-BAE0-B8EF03815A60 Q48293286-4FD1EABC-1ADE-494E-9D70-B383564AB141 Q48818532-1B07C8C9-BA6C-49DA-8756-D2D6B4B30C49 Q50963120-7F3F8EF0-902A-4131-A149-F3D36587CD59 Q51757573-27DFDDBA-FACB-4FDF-9F23-53ACF7E3C8AD Q51919506-C2A440D0-316C-4EE9-9E2C-524BE7540302

P2860

Preventing disturbing migraine aura with lamotrigine: an open study.

http://www.wikidata.org/entity/Q34650041

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Preventing disturbing migraine aura with lamotrigine: an open study.

@ast

Preventing disturbing migraine aura with lamotrigine: an open study.

@en

Preventing disturbing migraine aura with lamotrigine: an open study.

@nl

type

label

Preventing disturbing migraine aura with lamotrigine: an open study.

@ast

Preventing disturbing migraine aura with lamotrigine: an open study.

@en

Preventing disturbing migraine aura with lamotrigine: an open study.

@nl

prefLabel

Preventing disturbing migraine aura with lamotrigine: an open study.

@ast

Preventing disturbing migraine aura with lamotrigine: an open study.

@en

Preventing disturbing migraine aura with lamotrigine: an open study.

@nl

P1433

Q34650041-3B1C66DD-5BA1-4AF2-9417-4D32D7663CB3

P1476

Q34650041-050D0FFE-CE1B-40B4-BCEF-BA4D6AB1DAAC

P2093

Q34650041-135DE4A9-B33A-44A8-B48F-770DA616DE0A

Q34650041-297050BF-6951-4B60-89BF-183B63511284

Q34650041-3615BB6E-9A3E-453F-94AD-870F954DAE0D

Q34650041-509E344D-6C28-4A99-B78F-2F8175350377

Q34650041-9611454B-08D4-42B7-A663-52132D0A5A18

Q34650041-D185D9E9-952D-461A-AD46-D6748D3B6322

Q34650041-D916B4A1-640E-4FD0-9510-3AED0A8E6271

P2860

Q34650041-27D5263D-F615-4D18-A4D2-F3555A329A82

Q34650041-2DE6533C-B904-4FDC-8BB6-D844FBB3B0FC

Q34650041-47EEADA6-17B3-4945-ADAB-73348790DF5F

Q34650041-82E8E284-2BF2-4AD5-9660-10643F0E4DDB

Q34650041-A12AC72F-4558-45CE-B787-5C6CE2C87BDF

Q34650041-A6D1B8DD-CC74-4692-A6FC-C1FD79BF4436

Q34650041-BE66263C-0630-4AAC-BF9B-6A549DFA56B5

P304

Q34650041-AFA298F6-03BB-4C9B-AA40-F49E530847AF

P31

Q34650041-ECA5F454-5BEA-415E-96D6-380DE72F7649

P356

Q34650041-0BE8E2A2-030D-463E-891D-556DF3361B7F

P433

Q34650041-74A085DB-C425-4A89-93AF-8267A7E2FA0C

P478

Q34650041-1A8AE30F-F656-4511-A9EF-1B1A6F3562B2

P577

Q34650041-ABF4E602-9E0A-4185-B4DE-CBD844C2983F

P5875

Q34650041-A306D4AF-706D-49EB-B018-F6B827DBC38A

P698

Q34650041-724B9CFB-0D28-4992-BDFD-C91C517C7A80

P921

Q34650041-75FFB463-241C-4E34-9C12-6D35A0637AD7

P356

J.1526-4610.2004.04198.X

P1433

P1476

Preventing disturbing migraine aura with lamotrigine: an open study.

@en

P2093

Ana B Caminero

http://www.w3.org/2001/XMLSchema#string

Carlos García-Moncó

http://www.w3.org/2001/XMLSchema#string

Carlos Roig

http://www.w3.org/2001/XMLSchema#string

Julio Pascual

http://www.w3.org/2001/XMLSchema#string

Miguel J Laínez

http://www.w3.org/2001/XMLSchema#string

Rogelio Leira

http://www.w3.org/2001/XMLSchema#string

Valentín Mateos

http://www.w3.org/2001/XMLSchema#string

P2860

Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.

Persistent migrainous visual phenomena might be responsive to lamotrigine.

Familial hemiplegic migraine and its abortive therapy with intravenous verapamil.

Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil.

Efficacy of topiramate in migraine aura prophylaxis: preliminary results of 12 patients.

Migrainous stroke causing thalamic infarction and amnesia during treatment with propranolol.

Subcutaneous sumatriptan during the migraine aura

P304

1024-1028

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1526-4610.2004.04198.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8181317

http://www.w3.org/2001/XMLSchema#string

P698

15546267

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder